A letter was sent to advise healthcare professionals about a restriction to the indication and route of administration for Mitomycin-C Kyowa 40 mg following the observation of increased sub-visible particles in the drug product on storage. A letter was also sent to notify healthcare professionals of a risk of medication error with various Santen eye drop products during the period of transition to new bottles.